Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus

Abstract

Diabetes mellitus (DM) may cause an increase in the inflammatory status and oxidative stress as well as sympathetic nervous system overactivity, even in the absence of any other organic heart disease. We investigated the effect of perindopril, an angiotensin-converting enzyme inhibitor (ACE-i), on indexes of systemic inflammation and oxidative stress in normotensive patients with type 2 DM. We also examined the effect of the drug on the disturbances of left ventricular myocardial adrenergic innervation that may be seen in these patients. We studied 62 normotensive patients with type 2 DM, who were randomized to receive perindopril (n=32) or placebo (n=30). At the start of the study and after 6 months' therapy blood samples were taken to evaluate total peroxides (TP), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α), and the patients underwent a 123I-metaiodobenzylguanidine myocardial scintigraphy study. ACE-i caused a significant reduction in levels of cytokines and TP (P<0.001 for IL-6 and TNF-α, P=0.001 for TP). There was also a reduction in total defect score (P<0.001) and the heart to mediastinum ratio at 10 min and 4 h was improved (P<0.001 for both). No significant alterations were observed in the placebo group. Our data indicate that the addition of ACE-i to the medication of normotensive diabetic type 2 patients may improve the disturbed myocardial adrenergic innervation, the systemic inflammatory status and oxidative stress. Our findings indicate the cardioprotective action of ACE-i and suggest that earlier treatment might be appropriate in those patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Beckman JA, Goldfine AB, Gordon MB, Creager MA . Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001; 103: 1618–1623.

    Article  CAS  Google Scholar 

  2. Pickup JC . Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004; 27: 813–882.

    Article  Google Scholar 

  3. Libby P . Changing concepts of atherogenesis. J Intern Med 2000; 247: 349–358.

    Article  CAS  Google Scholar 

  4. Straub RH, Linde H, Mannel DN, Scholmerich J, Falk W . A bacteria-induced switch of sympathetic effector mechanisms augments local inhibition of TNF-α and IL-6 secretion in the spleen. FASEB J 2000; 14: 1380–1388.

    CAS  PubMed  Google Scholar 

  5. Opere CA, Opere D, Ohia SE . Mechanism of peroxide-induced potentiation of sympathetic neurotransmission in bovine irides: role of extracellular calcium. Free Radic Res 1998; 28: 283–292.

    Article  CAS  Google Scholar 

  6. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145–153.

    Article  CAS  Google Scholar 

  7. Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S et al. Perindopril effects on ambulatory blood pressure: relation to sympathetic nervous activity in subjects with diabetic nephropathy. Am J Hypertens 2004; 17: 14–20.

    Article  CAS  Google Scholar 

  8. Manolis AJ, Iraklianou S, Pittaras A, Zairis M, Tsioufis K, Psaltiras G et al. Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy. Am J Hypertens 2005; 18: 18–22.

    Article  CAS  Google Scholar 

  9. World Health Organization Study Group. Diabetes Mellitus, Technical report series no. 727 Geneva: World Health Organization, 1985.

  10. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH . Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767–1772.

    Article  CAS  Google Scholar 

  11. Ikeda U, Ito T, Shimada K . Interleukin-6 and acute coronary syndrome. Clin Cardiol 2001; 24: 701–704.

    Article  CAS  Google Scholar 

  12. Pliquett RU, Fasshauer M, Bluher M, Paschke R . Neurohumoral stimulation in type-2-diabetes as an emerging disease concept. Cardiovasc Diabetol 2004; 3: 4.

    Article  CAS  Google Scholar 

  13. Paulson DJ, Light KE . Elevation of serum and ventricular norepinephrine content in the diabetic rat. Res Commun Chem Pathol Pharmacol 1981; 33: 559–562.

    CAS  PubMed  Google Scholar 

  14. Schnell O, Muhr D, Weiss M, Kirsch C, Haslbeck M, Tatsch K et al. Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. J Diab Complications 1997; 5: 307–313.

    Article  Google Scholar 

  15. Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non–insulin-dependent diabetes mellitus. J Nucl Cardiol 2006; 13: 34–42.

    Article  Google Scholar 

  16. Hesse B, Meyer C, Nielsen FS, Sato A, Hove JD, Holm S et al. Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition. Eur J Nucl Med Mol Imaging 2004; 31: 362–368.

    Article  CAS  Google Scholar 

  17. Weiss D, Sorescu Taylor WR . Angiotensin II and atherosclerosis. Am J Cardiol 2001; 87: 25C–32C.

    Article  CAS  Google Scholar 

  18. Koh KK, Ahn JY, Han SH, Kim DS, Jin DK, Shin MS et al. Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J Am Coll Cardiol 2003; 42: 905–910.

    Article  CAS  Google Scholar 

  19. Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, Hori M . Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 2003; 169: 155–158.

    Article  CAS  Google Scholar 

  20. Kontopoulos AG, Athyros VG, Didangelos TP . Effects of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diab Care 1997; 20: 355–361.

    Article  CAS  Google Scholar 

  21. Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non–insulin-dependent diabetes mellitus. J Nucl Cardiol 2006; 13: 34–42.

    Article  Google Scholar 

  22. Story DF, Ziogas J . Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol Sci 1987; 8: 269–271.

    Article  CAS  Google Scholar 

  23. Esler M . Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function. J Hypertens 2002; 20: S13–S19.

    CAS  Google Scholar 

  24. Malik KU . Prostaglandins-modulation of adrenergic nervous system. Fed Proc 1978; 37: 203–207.

    CAS  PubMed  Google Scholar 

  25. Schmidt A, Grossmann G, Hauner H, Koenig W, Jansen T, Stauch M et al. Left ventricular function and wall thickness in long-term insulin-dependent diabetes mellitus: an echocardiographic study. J Int Med 1991; 229: 527–531.

    Article  CAS  Google Scholar 

  26. Waeber B, Nussberger J, Perret L, Santoni JP, Brunner HR . Experience with perindopril in normal volunteers. Clin Exp Hypertens A 1989; 11: 507–519.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P E Vardas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marketou, M., Zacharis, E., Koukouraki, S. et al. Effect of angiotensin-converting enzyme inhibitors on systemic inflammation and myocardial sympathetic innervation in normotensive patients with type 2 diabetes mellitus. J Hum Hypertens 22, 191–196 (2008). https://doi.org/10.1038/sj.jhh.1002310

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002310

Keywords

This article is cited by

Search

Quick links